drugset / Trial / NCT01140191
Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis
Phase 2
Terminated
1 enrolled
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR) · collabWalter Reed National Military Medical Center · collab
NaSingle-groupOpen-labelTreatment
Summary
The objectives of the study are to evaluate the safety, pharmacokinetics (PK), and efficacy of open label treatment with WR 279,396 (Topical Paromomycin/Gentamicin Cream)in subjects with cutaneous leishmaniasis (CL).
Timeline
- Start
- 2013-09
- Primary completion
- 2013-12
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gentamicin | Small molecule | 0.5 % | Topical |
| Subject | Paromomycin | Small molecule | 15 % | Topical |